Randall E. Morris

11.1k total citations
201 papers, 7.9k citations indexed

About

Randall E. Morris is a scholar working on Surgery, Transplantation and Molecular Biology. According to data from OpenAlex, Randall E. Morris has authored 201 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Surgery, 77 papers in Transplantation and 58 papers in Molecular Biology. Recurrent topics in Randall E. Morris's work include Renal Transplantation Outcomes and Treatments (74 papers), Transplantation: Methods and Outcomes (64 papers) and Organ Transplantation Techniques and Outcomes (25 papers). Randall E. Morris is often cited by papers focused on Renal Transplantation Outcomes and Treatments (74 papers), Transplantation: Methods and Outcomes (64 papers) and Organ Transplantation Techniques and Outcomes (25 papers). Randall E. Morris collaborates with scholars based in United States, Switzerland and Germany. Randall E. Morris's co-authors include Jan Gummert, F KUHN, C. Douglas Witherspoon, R. Shorthouse, Gerald J. Berry, Uwe Christians, Teun van Gelder, Clare R. Gregory, Margaret E. Billingham and Tuija Ikonen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation.

In The Last Decade

Randall E. Morris

199 papers receiving 7.7k citations

Peers

Countries citing papers authored by Randall E. Morris

Since Specialization

Citations

This map shows the geographic impact of Randall E. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall E. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall E. Morris more than expected).

Fields of papers citing papers by Randall E. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall E. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall E. Morris. The network helps show where Randall E. Morris may publish in the future.

Co-authorship network of co-authors of Randall E. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Randall E. Morris. A scholar is included among the top collaborators of Randall E. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall E. Morris. Randall E. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report 2020 ·American Journal of Transplantation ·Roslyn B. Mannon, Randall E. Morris, Michaël Abécassis, David A. Axelrod, (unknown), Gary S. Friedman, Peter S. Heeger, Krista L. Lentine, Alexandre Loupy, Barbara Murphy, Peter Nickerson, Minnie Sarwal, Inish O’Doherty, (unknown), (unknown)	12
2	Human Macrophages Do Not Require Phagosome Acidification to Mediate Fungistatic/Fungicidal Activity against Histoplasma capsulatum 2006 ·The Journal of Immunology ·Simon L. Newman, L Gootee, (unknown), Randall E. Morris	37
3	The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro 2005 ·Transplant International ·(unknown), Camille Dambrin, Derrick G. Freitag, Randall W. Yatscoff, Randall E. Morris	33
4	Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFAT 2004 ·Transplant International ·(unknown), Camille Dambrin, Kennan C. Marsh, Wolfgang Jacobsen, Stevan W. Djurić, Karl W. Mollison, Uwe Christians, George W. Carter, Randall E. Morris	15
5	Anti‐non‐Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF‐transgenic porcine hearts in cynomolgus monkeys 2004 ·Xenotransplantation ·Tuan T. Lam, Ricardo Paniagua, Giridhar M. Shivaram, Henk‐Jan Schuurman, (unknown), Randall E. Morris	50
6	The future of immunosuppression: a personal view 2004 ·Transplantation Proceedings ·Randall E. Morris	3
7	In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs 2004 ·Journal of Immunological Methods ·Mona G. Flores, (unknown), (unknown), Bari Holm, Bruce A. Reitz, Randall E. Morris, Dominic Borie	18
8	Treatment by Mycophenolate Mofetil of Advanced Graft Vascular Disease in Non‐Human Primate Recipients of Orthotopic Aortic Allografts 2003 ·American Journal of Transplantation ·J Klupp, Camille Dambrin, Kiyoshi Hibi, (unknown), Takeshi Suzuki, Bernard Hausen, Tudor Bı̂rsan, Teun van Gelder, Peter J. Fitzgerald, Gerald J. Berry, Randall E. Morris	18
9	Weight gain after lung transplantation 2003 ·The Journal of Heart and Lung Transplantation ·L.G. Singer, Timothy R. Brazelton, Ramona L. Doyle, Randall E. Morris, James Theodore	43
10	Novel assays of multiple lymphocyte functions in whole blood measure 2002 ·Transplant Immunology ·M.J. Barten, Teun van Gelder, Jan Gummert, R. Shorthouse, Randall E. Morris	33
11	Co-administration of tacrolimus and mycophenolate mofetil does not increase mycophenolic acid (MPA) exposure, but co-administration of cyclosporine inhibits the enterohepatic recirculation of MPA, thereby decreasing its exposure 2001 ·The Journal of Heart and Lung Transplantation ·Teun van Gelder, J Klupp, Markus J. Barten, Uwe Christians, Randall E. Morris	18
12	Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays 2001 ·Transplantation Proceedings ·M.J. Barten, Jan Gummert, Teun van Gelder, R. Shorthouse, Randall E. Morris	5
13	Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid 2001 ·Therapeutic Drug Monitoring ·Teun van Gelder, J Klupp, M.J. Barten, Uwe Christians, Randall E. Morris	261
14	Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening 2000 ·Transplant International ·Tuija Ikonen, Jan Gummert, Natalie J. Serkova, Motoya Hayase, Yasuhiro Honda, (unknown), Bernard Hausen, Paul G. Yock, Uwe Christians, Randall E. Morris	21
15	Newer Immunosuppressive Drugs 1999 ·Journal of the American Society of Nephrology ·Jan Gummert, Tuija Ikonen, Randall E. Morris	187
16	Mechanism of Action for Leflunomide in Rheumatoid Arthritis 1999 ·Clinical Immunology ·Robert I. Fox, Matthias Herrmann, Costakis Frangou, Geoffrey M. Wahl, Randall E. Morris, Vibeke Strand, Bernhard J. Kirschbaum	312
17	Leflunomide and Malononitrilamides 1997 ·The American Journal of the Medical Sciences ·Hélio Tedesco‐Silva, Randall E. Morris	83
18	Effect of immunosuppression on obliterative lesions in a heterotopic large-animal bronchial allograft model 1997 ·Transplantation Proceedings ·U.-S. Salminen, (unknown), Tuija Ikonen, E Taskinen, Randall E. Morris, Ari Harjula	4
19	Transvalvular left ventricular assistance in cardiogenic shock secondary to acute myocardial infarction 1994 ·Journal of the American College of Cardiology ·Richard W. Smalling, (unknown), Bruce Lachterman, Mary Jane Hess, Randall E. Morris, (unknown), Jacques Heibig, George Li, James T. Willerson, O.H. Frazier, Richard K. Wampler	20
20	Immunopharmacology of new xenobiotic immunosuppressive molecules. 1992 ·PubMed ·Randall E. Morris	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact